Tapewire

Nasdaq · USD

NKTR

NEKTAR THERAPEUTICS

Export transactions ↓
Tapewire entity
4364
SEC CIK
0000906709
Parsed reports
471

Last 12 months

Inside the activity.

0 purchase rows · 16 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202503
Dec 202500
Jan 202601
Feb 202602
Mar 202600
Apr 202600
May 202602
Jun 202606
Jul 202600
Aug 202602
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 17, 2019 Filed Jun 19, 2019 21:50 UTC
Labrucherie Gil MSVP & Chief Financial Officer
SaleCommon Stock 25,000 $33.71 $842,750.00
Disclosure

SEC source: 0001209191-19-038099 · doc4.xml · nonDerivative · entry 2

Labrucherie Gil M · CIK 0001394875 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 127,935

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Labrucherie for stock options scheduled to expire on February 7, 2020.

F3 · price: This transaction was executed in multiple trades at prices ranging from $33.37 to $33.91. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

F2 · balance_after: This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 4,218 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c).

Read SEC document
June 17, 2019 Filed Jun 19, 2019 21:50 UTC
Labrucherie Gil MSVP & Chief Financial Officer
Exercise / conversionCommon Stock 25,000 $7.21 $180,250.00
Disclosure

SEC source: 0001209191-19-038099 · doc4.xml · nonDerivative · entry 1

Labrucherie Gil M · CIK 0001394875 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 152,935

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Labrucherie for stock options scheduled to expire on February 7, 2020.

F2 · balance_after: This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 4,218 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c).

Read SEC document
May 23, 2019 Filed May 23, 2019 23:19 UTC
ROBIN HOWARD WDirector · President & CEO
Exercise / conversionCommon Stock · Derivative 33,333 $0.00 Strike: $7.21 $0.00
Disclosure

SEC source: 0001209191-19-032499 · doc4.xml · derivative · entry 10

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 33,333 shares

Expires 2020-02-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Robin for certain options expiring on February 7, 2020.

Read SEC document
May 23, 2019 Filed May 23, 2019 23:19 UTC
ROBIN HOWARD WDirector · President & CEO
SaleCommon Stock 33,333 $32.69 $1,089,655.77
Disclosure

SEC source: 0001209191-19-032499 · doc4.xml · nonDerivative · entry 6

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 295,326

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Robin for certain options expiring on February 7, 2020.

F4 · price: This transaction was executed in multiple trades at prices ranging from $32.02 to $33.05. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

Read SEC document
May 23, 2019 Filed May 23, 2019 23:19 UTC
ROBIN HOWARD WDirector · President & CEO
Exercise / conversionCommon Stock 33,333 $7.21 $240,330.93
Disclosure

SEC source: 0001209191-19-032499 · doc4.xml · nonDerivative · entry 5

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 328,659

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Robin for certain options expiring on February 7, 2020.

Read SEC document
May 22, 2019 Filed May 23, 2019 23:19 UTC
ROBIN HOWARD WDirector · President & CEO
Exercise / conversionCommon Stock · Derivative 33,334 $0.00 Strike: $7.21 $0.00
Disclosure

SEC source: 0001209191-19-032499 · doc4.xml · derivative · entry 9

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,333

Underlying: Common Stock · 33,334 shares

Expires 2020-02-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Robin for certain options expiring on February 7, 2020.

Read SEC document
May 22, 2019 Filed May 23, 2019 23:19 UTC
ROBIN HOWARD WDirector · President & CEO
SaleCommon Stock 33,334 $33.38 $1,112,688.92
Disclosure

SEC source: 0001209191-19-032499 · doc4.xml · nonDerivative · entry 4

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 295,326

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Robin for certain options expiring on February 7, 2020.

F3 · price: This transaction was executed in multiple trades at prices ranging from $33.07 to $33.67. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

Read SEC document
May 22, 2019 Filed May 23, 2019 23:19 UTC
ROBIN HOWARD WDirector · President & CEO
Exercise / conversionCommon Stock 33,334 $7.21 $240,338.14
Disclosure

SEC source: 0001209191-19-032499 · doc4.xml · nonDerivative · entry 3

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 328,660

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Robin for certain options expiring on February 7, 2020.

Read SEC document
May 21, 2019 Filed May 23, 2019 23:19 UTC
ROBIN HOWARD WDirector · President & CEO
Exercise / conversionCommon Stock · Derivative 33,333 $0.00 Strike: $7.21 $0.00
Disclosure

SEC source: 0001209191-19-032499 · doc4.xml · derivative · entry 8

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,667

Underlying: Common Stock · 33,333 shares

Expires 2020-02-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Robin for certain options expiring on February 7, 2020.

Read SEC document
May 21, 2019 Filed May 23, 2019 23:19 UTC
ROBIN HOWARD WDirector · President & CEO
SaleCommon Stock 33,333 $32.93 $1,097,655.69
Disclosure

SEC source: 0001209191-19-032499 · doc4.xml · nonDerivative · entry 2

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 295,326

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Robin for certain options expiring on February 7, 2020.

F2 · price: This transaction was executed in multiple trades at prices ranging from $32.43 to $33.45. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

Read SEC document
May 21, 2019 Filed May 23, 2019 23:19 UTC
ROBIN HOWARD WDirector · President & CEO
Exercise / conversionCommon Stock 33,333 $7.21 $240,330.93
Disclosure

SEC source: 0001209191-19-032499 · doc4.xml · nonDerivative · entry 1

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 328,659

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Robin for certain options expiring on February 7, 2020.

Read SEC document
May 16, 2019 Filed May 18, 2019 00:22 UTC
Thomsen Jillian B.SVP & Chief Accounting Officer
SaleCommon Stock 1,928 $31.37 $60,481.36
Disclosure

SEC source: 0001209191-19-031190 · doc4.xml · nonDerivative · entry 1

Thomsen Jillian B. · CIK 0001433457 · SVP & Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 164,463

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $30.86 to $32.68. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

F3 · balance_after: This number includes 988 shares held by the reporting person in the Issuer's 401(K) plan and 4,170 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c).

Read SEC document
May 16, 2019 Filed May 18, 2019 00:22 UTC
ROBIN HOWARD WDirector · President & CEO
SaleCommon Stock 13,383 $31.37 $419,824.71
Disclosure

SEC source: 0001209191-19-031189 · doc4.xml · nonDerivative · entry 1

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 295,326

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $30.86 to $32.68. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

Read SEC document
May 16, 2019 Filed May 18, 2019 00:20 UTC
Labrucherie Gil MSVP & Chief Financial Officer
SaleCommon Stock 3,767 $31.37 $118,170.79
Disclosure

SEC source: 0001209191-19-031187 · doc4.xml · nonDerivative · entry 1

Labrucherie Gil M · CIK 0001394875 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 127,935

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $30.86 to $32.68. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

F3 · balance_after: This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 4,218 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c).

Read SEC document
May 16, 2019 Filed May 18, 2019 00:21 UTC
Nicholson JohnSVP & Chief Operating Officer
SaleCommon Stock 4,077 $31.37 $127,895.49
Disclosure

SEC source: 0001209191-19-031188 · doc4.xml · nonDerivative · entry 1

Nicholson John · CIK 0001420766 · SVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 166,578

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $30.86 to $32.68. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

Read SEC document
May 16, 2019 Filed May 18, 2019 00:18 UTC
Doberstein Stephen KSVP & Chief Scientific Officer
SaleCommon Stock 3,461 $31.37 $108,571.57
Disclosure

SEC source: 0001209191-19-031184 · doc4.xml · nonDerivative · entry 1

Doberstein Stephen K · CIK 0001480111 · SVP & Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,913

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $30.86 to $32.68. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

Read SEC document
May 16, 2019 Filed May 18, 2019 00:19 UTC
Hora ManinderSVP Pharma Dev & Mfg Ops
SaleCommon Stock 2,449 $31.37 $76,825.13
Disclosure

SEC source: 0001209191-19-031185 · doc4.xml · nonDerivative · entry 1

Hora Maninder · CIK 0001443159 · SVP Pharma Dev & Mfg Ops

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,694

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $30.86 to $32.68. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

F3 · balance_after: This number includes 6,968 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c).

Read SEC document
March 08, 2019 Filed Mar 12, 2019 22:18 UTC Exercise / conversionStock Option · Derivative 10,000 $0.00 Strike: $5.14 $0.00
Disclosure

SEC source: 0001209191-19-018968 · doc4.xml · derivative · entry 2

GREER R SCOTT · CIK 0001211703 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2019-09-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 08, 2019 Filed Mar 12, 2019 22:18 UTC Exercise / conversionCommon Stock 10,000 $5.14 $51,400.00
Disclosure

SEC source: 0001209191-19-018968 · doc4.xml · nonDerivative · entry 1

GREER R SCOTT · CIK 0001211703 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 145,083

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 21, 2019 Filed Feb 22, 2019 01:16 UTC
ROBIN HOWARD WDirector · President & CEO
Exercise / conversionCommon Stock · Derivative 33,333 $0.00 Strike: $7.21 $0.00
Disclosure

SEC source: 0001209191-19-012336 · doc4.xml · derivative · entry 11

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 33,333 shares

Expires 2020-02-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Robin for certain options expiring on February 7, 2020.

Read SEC document
February 21, 2019 Filed Feb 22, 2019 01:16 UTC
ROBIN HOWARD WDirector · President & CEO
SaleCommon Stock 33,333 $41.01 $1,366,986.33
Disclosure

SEC source: 0001209191-19-012336 · doc4.xml · nonDerivative · entry 7

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 308,709

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Robin for certain options expiring on February 7, 2020.

F6 · price: This transaction was executed in multiple trades at prices ranging from $40.24 to $42.77. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

Read SEC document
February 21, 2019 Filed Feb 22, 2019 01:16 UTC
ROBIN HOWARD WDirector · President & CEO
Exercise / conversionCommon Stock 33,333 $7.21 $240,330.93
Disclosure

SEC source: 0001209191-19-012336 · doc4.xml · nonDerivative · entry 6

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 342,042

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Robin for certain options expiring on February 7, 2020.

Read SEC document
February 20, 2019 Filed Feb 22, 2019 01:16 UTC
ROBIN HOWARD WDirector · President & CEO
Exercise / conversionCommon Stock · Derivative 33,334 $0.00 Strike: $7.21 $0.00
Disclosure

SEC source: 0001209191-19-012336 · doc4.xml · derivative · entry 10

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 133,333

Underlying: Common Stock · 33,334 shares

Expires 2020-02-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Robin for certain options expiring on February 7, 2020.

Read SEC document
February 20, 2019 Filed Feb 22, 2019 01:16 UTC
ROBIN HOWARD WDirector · President & CEO
SaleCommon Stock 33,334 $43.20 $1,440,028.80
Disclosure

SEC source: 0001209191-19-012336 · doc4.xml · nonDerivative · entry 5

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 308,709

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Robin for certain options expiring on February 7, 2020.

F5 · price: This transaction was executed in multiple trades at prices ranging from $42.82 to $44.04. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

Read SEC document
February 20, 2019 Filed Feb 22, 2019 01:16 UTC
ROBIN HOWARD WDirector · President & CEO
Exercise / conversionCommon Stock 33,334 $7.21 $240,338.14
Disclosure

SEC source: 0001209191-19-012336 · doc4.xml · nonDerivative · entry 4

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 342,043

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Robin for certain options expiring on February 7, 2020.

Read SEC document
February 19, 2019 Filed Feb 22, 2019 01:17 UTC
Thomsen Jillian B.SVP & Chief Accounting Officer
SaleCommon Stock 1,808 $42.39 $76,641.12
Disclosure

SEC source: 0001209191-19-012337 · doc4.xml · nonDerivative · entry 1

Thomsen Jillian B. · CIK 0001433457 · SVP & Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 166,391

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $41.90 to $42.96. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

F3 · balance_after: This number includes 988 shares held by the reporting person in the Issuer's 401(K) plan and 4,170 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c).

Read SEC document
February 19, 2019 Filed Feb 22, 2019 01:14 UTC
Labrucherie Gil MSVP & Chief Financial Officer
SaleCommon Stock 3,592 $42.39 $152,264.88
Disclosure

SEC source: 0001209191-19-012334 · doc4.xml · nonDerivative · entry 1

Labrucherie Gil M · CIK 0001394875 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 131,702

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $41.90 to $42.96. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

F3 · balance_after: This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 4,218 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c).

Read SEC document
February 19, 2019 Filed Feb 22, 2019 01:16 UTC
ROBIN HOWARD WDirector · President & CEO
Exercise / conversionCommon Stock · Derivative 33,333 $0.00 Strike: $7.21 $0.00
Disclosure

SEC source: 0001209191-19-012336 · doc4.xml · derivative · entry 9

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 166,667

Underlying: Common Stock · 33,333 shares

Expires 2020-02-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Robin for certain options expiring on February 7, 2020.

Read SEC document
February 19, 2019 Filed Feb 22, 2019 01:16 UTC
ROBIN HOWARD WDirector · President & CEO
SaleCommon Stock 8,882 $42.39 $376,507.98
Disclosure

SEC source: 0001209191-19-012336 · doc4.xml · nonDerivative · entry 3

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 308,709

F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F4 · price: This transaction was executed in multiple trades at prices ranging from $41.90 to $42.96. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

Read SEC document
February 19, 2019 Filed Feb 22, 2019 01:16 UTC
ROBIN HOWARD WDirector · President & CEO
SaleCommon Stock 33,333 $42.32 $1,410,652.56
Disclosure

SEC source: 0001209191-19-012336 · doc4.xml · nonDerivative · entry 2

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 317,591

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Robin for certain options expiring on February 7, 2020.

F2 · price: This transaction was executed in multiple trades at prices ranging from $41.87 to $42.91. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

Read SEC document
February 19, 2019 Filed Feb 22, 2019 01:16 UTC
ROBIN HOWARD WDirector · President & CEO
Exercise / conversionCommon Stock 33,333 $7.21 $240,330.93
Disclosure

SEC source: 0001209191-19-012336 · doc4.xml · nonDerivative · entry 1

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 350,924

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Robin for certain options expiring on February 7, 2020.

Read SEC document
February 19, 2019 Filed Feb 22, 2019 01:15 UTC
Nicholson JohnSVP & Chief Operating Officer
SaleCommon Stock 3,822 $42.39 $162,014.58
Disclosure

SEC source: 0001209191-19-012335 · doc4.xml · nonDerivative · entry 1

Nicholson John · CIK 0001420766 · SVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 170,655

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $41.90 to $42.96. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

Read SEC document
February 19, 2019 Filed Feb 22, 2019 01:13 UTC
Hora ManinderSVP Pharma Dev & Mfg Ops
SaleCommon Stock 2,386 $42.39 $101,142.54
Disclosure

SEC source: 0001209191-19-012333 · doc4.xml · nonDerivative · entry 1

Hora Maninder · CIK 0001443159 · SVP Pharma Dev & Mfg Ops

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 97,143

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $41.90 to $42.96. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

F3 · balance_after: This number includes 6,968 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c).

Read SEC document
February 19, 2019 Filed Feb 22, 2019 01:13 UTC
Doberstein Stephen KSVP & Chief Scientific Officer
SaleCommon Stock 3,310 $42.39 $140,310.90
Disclosure

SEC source: 0001209191-19-012332 · doc4.xml · nonDerivative · entry 1

Doberstein Stephen K · CIK 0001480111 · SVP & Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 99,374

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $41.90 to $42.96. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

Read SEC document
February 04, 2019 Filed Feb 7, 2019 00:17 UTC
Thomsen Jillian B.SVP & Chief Accounting Officer
Exercise / conversionStock Option · Derivative 16,119 $0.00 Strike: $10.69 $0.00
Disclosure

SEC source: 0001209191-19-007880 · doc4.xml · derivative · entry 3

Thomsen Jillian B. · CIK 0001433457 · SVP & Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 16,119 shares

Expires 2019-02-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for certain options expiring on February 7, 2019.

Read SEC document
February 04, 2019 Filed Feb 7, 2019 00:17 UTC
Thomsen Jillian B.SVP & Chief Accounting Officer
SaleCommon Stock 16,119 $42.16 $679,577.04
Disclosure

SEC source: 0001209191-19-007880 · doc4.xml · nonDerivative · entry 2

Thomsen Jillian B. · CIK 0001433457 · SVP & Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 168,199

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for certain options expiring on February 7, 2019.

F3 · price: This transaction was executed in multiple trades at prices ranging from $42.15 to $42.24. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

F2 · balance_after: This number includes 988 shares held by the reporting person in the Issuer's 401(K) plan and 4,170 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c).

Read SEC document
February 04, 2019 Filed Feb 7, 2019 00:17 UTC
Thomsen Jillian B.SVP & Chief Accounting Officer
Exercise / conversionCommon Stock 16,119 $10.69 $172,312.11
Disclosure

SEC source: 0001209191-19-007880 · doc4.xml · nonDerivative · entry 1

Thomsen Jillian B. · CIK 0001433457 · SVP & Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 184,318

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for certain options expiring on February 7, 2019.

F2 · balance_after: This number includes 988 shares held by the reporting person in the Issuer's 401(K) plan and 4,170 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c).

Read SEC document
January 28, 2019 Filed Jan 30, 2019 23:02 UTC
Nicholson JohnSVP & Chief Operating Officer
Exercise / conversionStock Option · Derivative 63,000 $10.69 Strike: $10.69 $673,470.00
Disclosure

SEC source: 0001209191-19-006044 · doc4.xml · derivative · entry 3

Nicholson John · CIK 0001420766 · SVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 63,000 shares

Expires 2019-02-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Nicholson for certain options expiring on February 7, 2019.

Read SEC document
January 28, 2019 Filed Jan 30, 2019 23:02 UTC
Nicholson JohnSVP & Chief Operating Officer
SaleCommon Stock 63,000 $42.82 $2,697,660.00
Disclosure

SEC source: 0001209191-19-006044 · doc4.xml · nonDerivative · entry 2

Nicholson John · CIK 0001420766 · SVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 174,477

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Nicholson for certain options expiring on February 7, 2019.

F2 · price: This transaction was executed in multiple trades at prices ranging from $42.31 to $43.55. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

Read SEC document
January 28, 2019 Filed Jan 30, 2019 23:02 UTC
Nicholson JohnSVP & Chief Operating Officer
Exercise / conversionCommon Stock 63,000 $10.69 $673,470.00
Disclosure

SEC source: 0001209191-19-006044 · doc4.xml · nonDerivative · entry 1

Nicholson John · CIK 0001420766 · SVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 237,477

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Nicholson for certain options expiring on February 7, 2019.

Read SEC document
December 14, 2018 Filed Dec 18, 2018 23:14 UTC
Thomsen Jillian B.SVP & Chief Accounting Officer
GrantStock Option · Derivative 22,150 $0.00 Strike: $36.51 $0.00
Disclosure

SEC source: 0001209191-18-063302 · doc4.xml · derivative · entry 2

Thomsen Jillian B. · CIK 0001433457 · SVP & Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,150

Underlying: Common Stock · 22,150 shares

Expires 2026-12-13

F3 · derivative.exercise_date: This stock option vests over four years in equal monthly installments based on continued service.

Read SEC document
December 14, 2018 Filed Dec 18, 2018 23:14 UTC
Thomsen Jillian B.SVP & Chief Accounting Officer
GrantCommon Stock 10,950 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-063302 · doc4.xml · nonDerivative · entry 1

Thomsen Jillian B. · CIK 0001433457 · SVP & Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 168,199

F1 · security: This stock award was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, upon vesting of the unit, one share of the issuer's common stock. These RSUs vest over three years in substantially equal quarterly installments based on continued service.

F2 · balance_after: This number includes 988 shares held by the reporting person in the Issuer's 401(K) plan and 4,170 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c).

Read SEC document
December 14, 2018 Filed Dec 18, 2018 23:13 UTC
ROBIN HOWARD WDirector · President & CEO
GrantStock Option · Derivative 138,350 $0.00 Strike: $36.51 $0.00
Disclosure

SEC source: 0001209191-18-063301 · doc4.xml · derivative · entry 3

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 138,350

Underlying: Common Stock · 138,350 shares

Expires 2026-12-13

F2 · derivative.exercise_date: This stock option vests over four years in equal monthly installments based on continued service.

Read SEC document
December 14, 2018 Filed Dec 18, 2018 23:13 UTC
ROBIN HOWARD WDirector · President & CEO
GrantCommon Stock 68,450 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-063301 · doc4.xml · nonDerivative · entry 1

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 317,591

F1 · security: This stock award was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, upon vesting of the unit, one share of the issuer's common stock. These RSUs vest over three years in substantially equal quarterly installments based on continued service.

Read SEC document
December 14, 2018 Filed Dec 18, 2018 23:12 UTC
Labrucherie Gil MSVP & Chief Financial Officer
GrantStock Option · Derivative 58,100 $0.00 Strike: $36.51 $0.00
Disclosure

SEC source: 0001209191-18-063300 · doc4.xml · derivative · entry 2

Labrucherie Gil M · CIK 0001394875 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,100

Underlying: Common Stock · 58,100 shares

Expires 2026-12-13

F3 · derivative.exercise_date: This stock option vests over four years in equal monthly installments based on continued service.

Read SEC document
December 14, 2018 Filed Dec 18, 2018 23:12 UTC
Labrucherie Gil MSVP & Chief Financial Officer
GrantCommon Stock 28,750 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-063300 · doc4.xml · nonDerivative · entry 1

Labrucherie Gil M · CIK 0001394875 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 135,294

F1 · security: This stock award was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, upon vesting of the unit, one share of the issuer's common stock. These RSUs vest over three years in substantially equal quarterly installments based on continued service.

F2 · balance_after: This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 4,218 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c).

Read SEC document
December 14, 2018 Filed Dec 18, 2018 23:11 UTC
Hora ManinderSVP Pharma Dev & Mfg Ops
GrantStock Option · Derivative 37,350 $0.00 Strike: $36.51 $0.00
Disclosure

SEC source: 0001209191-18-063299 · doc4.xml · derivative · entry 2

Hora Maninder · CIK 0001443159 · SVP Pharma Dev & Mfg Ops

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,350

Underlying: Common Stock · 37,350 shares

Expires 2026-12-13

F3 · derivative.exercise_date: This stock option vests over four years in equal monthly installments based on continued service.

Read SEC document
December 14, 2018 Filed Dec 18, 2018 23:11 UTC
Hora ManinderSVP Pharma Dev & Mfg Ops
GrantCommon Stock 18,500 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-063299 · doc4.xml · nonDerivative · entry 1

Hora Maninder · CIK 0001443159 · SVP Pharma Dev & Mfg Ops

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 99,529

F1 · security: This stock award was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, upon vesting of the unit, one share of the issuer's common stock. These RSUs vest over three years in substantially equal quarterly installments based on continued service.

F2 · balance_after: This number includes 6,968 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c).

Read SEC document
December 14, 2018 Filed Dec 18, 2018 23:10 UTC
Doberstein Stephen KSVP & Chief Scientific Officer
GrantStock Option · Derivative 48,400 $0.00 Strike: $36.51 $0.00
Disclosure

SEC source: 0001209191-18-063297 · doc4.xml · derivative · entry 2

Doberstein Stephen K · CIK 0001480111 · SVP & Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,400

Underlying: Common Stock · 48,400 shares

Expires 2026-12-13

F2 · derivative.exercise_date: This stock option vests over four years in equal monthly installments based on continued service.

Read SEC document
December 14, 2018 Filed Dec 18, 2018 23:10 UTC
Doberstein Stephen KSVP & Chief Scientific Officer
GrantCommon Stock 23,950 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-063297 · doc4.xml · nonDerivative · entry 1

Doberstein Stephen K · CIK 0001480111 · SVP & Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,684

F1 · security: This stock award was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, upon vesting of the unit, one share of the issuer's common stock. These RSUs vest over three years in substantially equal quarterly installments based on continued service.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.